SMS Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
For the six months, sales was INR 2,238.22 million compared to INR 3,377.02 million a year ago. Revenue was INR 2,252.37 million compared to INR 3,403.43 million a year ago. Net loss was INR 147.75 million compared to net income of INR 465.9 million a year ago. Basic loss per share from continuing operations was INR 1.75 compared to basic earnings per share from continuing operations of INR 5.5 a year ago.